Home Diagnostics, Inc. (NASDAQ: HDIX) is this morning’s top pre-market gainer, on news of a buyout.  The company has agreed to be acquired by Nipro Corporation for $11.50 per share in a $215 million buyout.  This represents about a 90% premium to yesterday and about an 83% premium to the average closing price for the last 90 days.

The company makes blood glucose monitoring systems and disposable supplies for people with diabetes. If you wonder how the price was determined, this stock came public in late-2006 and briefly traded above $12.00 in 2006 and 2007.

At 8:27 AM EST we have seen some 1.12 million shares trade hands versus an average daily volume of only about 26,600 shares.  The stock is up 89% at $11.47 and the prior 52-week trading range is $4.62 to $7.71.

JON C. OGG